Oprah Winfrey reveals weight loss secret

Oprah reveals diabetes drug role in her weight loss journey
Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she revealed that this process helped her understand slim people. Oprah Winfrey has struggled with weight issues for years.
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
Benefits and risks of popular weight-loss drugs revealed
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes,
Oprah Winfrey Says Her Opinion of ‘Thin People’ Changed After She Used Weight Loss Drugs
"I thought that thin people just had more willpower,” the 70-year-old said Oprah Winfrey is opening up about the revelation she had about “thin people.” On the Jan. 14 episode of The Oprah Podcast, the former talk show host had a conversation with Yale University obesity medicine physician scientist Dr.
Oprah Winfrey reveals weight loss secret: Insights from using diabetes medication
Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she revealed that this process has helped her understand "thin" people. Oprah Winfrey has struggled with weight issues for years.
Oprah Winfrey Admits Weight Loss Journey Changed Her Perception of 'Thin People'
Oprah Winfrey shared on her podcast how Ozempic changed her views on "thin people," realizing food noise isn't just willpower.
Diabetes startup Virta Health is now prescribing Ozempic for weight loss in a push toward profitability and IPO
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer’s, Study Shows. What It Means for the Stocks.
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The ...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
News Medical6h
What causes behavioral side effects in popular weight loss drugs?
The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.
Popular weight loss drugs could be cheaper for some Americans: What you need to know
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
phillyvoice.com1d
Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...